Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 172,198 shares at $5.50 ($946K) on 2017-01-17, disclosed to the SEC on 2017-01-17.
Open-market purchase of $946k MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.50 | 49,776 | $274K | 28.9% |
| 2 | $5.49 | 52,311 | $287K | 30.4% |
| 3 | $5.49 | 52,311 | $287K | 30.4% |
| 4 | $5.50 | 17,800 | $98K | 10.3% |
| Total | $5.49 avg | 172,198 | $946K | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |